APCC 2017 Interviews - Chris Sweeney 2
Chris Sweeney discusses which is best? Abirateron…
An episode of the Talking Urology Podcast podcast, hosted by Talking Urology, titled "APCC 2017 Interviews - Chris Sweeney 2" was published on November 17, 2017 and runs 1 minutes.
November 17, 2017 ·1m · Talking Urology Podcast
Summary
Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer
Episode Description
Similar Episodes
Apr 9, 2026 ·35m
Apr 9, 2026 ·49m
Apr 6, 2026 ·14m
Apr 2, 2026 ·52m
Apr 1, 2026 ·41m
Apr 1, 2026 ·28m